Last updated: February 19, 2025
Sponsor: Gangnam Severance Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Osteomyelitis
Bone Neoplasm
Musculoskeletal Diseases
Treatment
Prepectoral
Subpectoral
Clinical Study ID
NCT06129214
3-2023-0282
Ages > 19 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
1.Patients who scheduled to perform both total knee arthroplasty(TKA) using posteiror crucitate sustain type (PS)
Exclusion
Exclusion Criteria:
Lost follow up (Including death of patient)
Unexpected complication (e.g) Infection, periprosthetic fracture)
Patella resurfacing
Canceled surgical treatment
Refused to enrolled study
Too much radiological or physicological variance shown between either knee
Study Design
Total Participants: 78
Treatment Group(s): 2
Primary Treatment: Prepectoral
Phase:
Study Start date:
October 16, 2023
Estimated Completion Date:
October 06, 2025
Study Description
Connect with a study center
Gangnam Severance Hospital
Seoul, GangnamGu
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.